Rapid complete cytogenetic remission after upfront dasatinib monotherapy in a patient with a NUP214-ABL1-positive T-cell acute lymphoblastic leukemia
(Letter To Editor)
Deenik, W. Beverloo, H.B. Poel-van de Luytgaarde, S.C.P.A.M. van der Wattel, M.M. Esser, J.W.J. van Valk, P.J.M. Cornelissen, J.J.
|
2009-01-01
|
Cardiopulmonary imaging, functional and laboratory studies in sickle cell disease associated pulmonary hypertension
(Article)
Beers, E.J. van Nur, E. Biemond, B.J. Schaefer-Prokop, C. Mac Gillavry, M.R. Esser, J.W.J. van Brandjes, D.P.M. Kappers-Klunne, M.C. Duits, A.J. Muskiet, F.A.J. Schnog, J.J.B.
|
2008-11-01
|
Association of asymmetric dimethylarginine with sickle cell disease-related pulmonary hypertension
(Article)
Landburg, P.P. Teerlink, T. Schnog, J.J.B. Beers, E.J. van Muskiet, F.A.J. Kappers-Klunne, M.C. Esser, J.W.J. van Mac Gillavry, M.R. Biemond, B.J. Brandjes, D.P.M. Duits, A.J.
|
2008-09-01
|
No association of the hypercoagulable state with sickle cell disease related pulmonary hypertension
(Article)
Beers, E.J. van Spronk, H.M.H. Cate, H. ten Duits, A.J. Brandjes, D.P.M. Esser, J.W.J. van Biemond, B.J. Schnog, J.J.B.
|
2008-05-01
|
Large and medium-sized pulmonary artery obstruction does not play a role of primary importance in the etiology of sickle-cell disease-associated pulmonary hypertension
(Article)
Beers, E.J. van Eck-Smit, B.L.F. van Mac Gillavry, M.R. Tuijn, C.F.J. van Esser, J.W.J. van Brandjes, D.P.M. Kappers-Klunne, M.C. Duits, A.J. Biemond, B.J. Schnog, J.J.B.
|
2008-03-01
|
Associations among Epstein-Barr virus subtypes, human leukocyte antigen class I alleles, and the development of posttransplantation lymphoproliferative disorder in bone marrow transplant recipients
(Article)
Görzer, I. Puchhammer-Stöckl, E. Esser, J.W.J. van Niesters, H.G.M. Cornelissen, J.J.
|
2007-03-01
|
Epstein-Barr Virus Lymphoproliferative Disease Following Allogeneic Hematopoietic Stem Cell Transplantation: Prediction and Early Intervention
(Doctoral Thesis)
Esser, J.W.J. van
|
2003-01-17
|
Impaired recovery of Epstein-Barr virus (EBV)--specific CD8+ T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk for progressive EBV reactivation and lymphoproliferative disease
(Article)
Meij, P. Löwenberg, B. Leiner, I. Pamer, E. Gratama, J-W. Cornelissen, J.J. Esser, J.W.J. van Niesters, H.G.M. Baarle, D. van Miedema, F. Blake, N. Rickinson, A.B.
|
2003-01-01
|
Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation
(Article)
Esser, J.W.J. van Niesters, H.G.M. Holt, B. van der Meijer, E. Osterhaus, A.D.M.E. Gratama, J-W. Verdonck, L.F. Löwenberg, B. Cornelissen, J.J.
|
2002-01-01
|
Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection
(Article)
Gratama, J-W. Esser, J.W.J. van Lamers, C.H.J. Tournay, C. Löwenberg, B. Bolhuis, R.L.H. Cornelissen, J.J.
|
2001-01-01
|